InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Kanes Stephen, Directeur médical. Director active across 2 companies, notably Sage Therapeutics, Inc.. Cumulatively, 4 reports have been logged. History available since 15 June 2021. The latest transaction was disclosed on 2 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kanes Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
120,000 股Ordinary SharesSEC:0001470831-26-000617:0
120,000 股0Ordinary SharesSEC:0001470831-26-000098:0
3,800 股0Common StockSEC:0001562180-21-006596:0
3,500 股0Common StockSEC:0001562180-21-004338:0
4 条申报中的 4 条
About Kanes Stephen
Stephen Kanes serves as the Chief Medical Officer at Sage Therapeutics, Inc. He is responsible for leading the company's clinical and research initiatives, ensuring alignment of medical objectives with overall strategy. His expertise in the pharmaceutical field contributes to the advancement of innovative treatments.
